Vault-13

Foresite Capital Management IV, LLC

WEST HOLLYWOOD, CA · CIK 1704132 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$290.2m reported value +22.4% vs Q1 2026
6positions
100.0%in top 10
1 new 2 added 0 reduced 3 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PHARVARIS N V COM PHVS PHVS 4,778,581 $165.2m56.95% 56.95% UnchangedShares held: Q3 2025 4.8m, Q4 2025 4.8m, Q1 2026 4.8m, Q2 2026 4.8m
2 CYTOKINETICS INC COM NEW CYTK CYTK 714,695 $60.9m20.98% 20.98% AddedShares held: Q3 2025 458.3k, Q4 2025 458.3k, Q1 2026 503.3k, Q2 2026 714.7k +211.4k +211,400 42.0%
3 EIKON THERAPEUTICS INC COM EIKN EIKN 1,943,682 $25.4m8.74% 8.74% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.9m, Q2 2026 1.9m
4 RELAY THERAPEUTICS INC COM RLAY RLAY 1,250,000 $23.4m8.06% 8.06% AddedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 1.0m, Q2 2026 1.2m +250.0k +250,000 25.0%
5 XENON PHARMACEUTICALS INC COM XENE XENE 160,000 $9.7m3.33% 3.33% UnchangedShares held: Q3 2025 160.0k, Q4 2025 160.0k, Q1 2026 160.0k, Q2 2026 160.0k
6 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 150,000 $5.6m1.93% 1.93% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
LYELL IMMUNOPHARMA INC LYEL LYEL 800,399 $16.1m800.4k shares
ALECTOR INC ALEC ALEC 3,887,200 $8.4m3.9m shares
MAZE THERAPEUTICS INC MAZE MAZE 156,901 $4.7m156.9k shares